Oryzon Genomics SA (ORY) — Financial Flexibility Index
Oryzon Genomics SA (ORY) has a Financial Flexibility Index of 0.20x as of June 2023. Free cash flow of €5.16 Million (operating CF €-2.41 Million minus capex €7.57 Million) represents 0% of total liabilities (€26.10 Million). Check Oryzon Genomics SA investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oryzon Genomics SA Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Oryzon Genomics SA across 13 annual periods. For the full cash flow conversion analysis, see Oryzon Genomics SA cash flow conversion.
Annual Financial Flexibility Index for Oryzon Genomics SA (2013–2025)
Year-by-year free cash flow to debt coverage for Oryzon Genomics SA. Explore ORY operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.09x | €-2.30 Million | €-2.36 Million | €26.68 Million | ▼ -192.4% |
| 2024 | 0.09x | €2.02 Million | €-5.69 Million | €21.67 Million | ▼ -83.2% |
| 2023 | 0.55x | €13.93 Million | €-574.96K | €25.13 Million | ▲ +38.9% |
| 2022 | 0.40x | €12.42 Million | €-1.85 Million | €31.13 Million | ▲ +18.3% |
| 2021 | 0.34x | €8.13 Million | €-3.63 Million | €24.12 Million | ▲ +39.1% |
| 2020 | 0.24x | €4.41 Million | €-4.82 Million | €18.18 Million | ▼ -99.7% |
| 2019 | 71.18x | €5.65 Million | €-3.93 Million | €79.38K | ▲ +320210.6% |
| 2018 | -0.02x | €-496.46K | €-666.09K | €22.33 Million | ▲ +87.1% |
| 2017 | -0.17x | €-4.60 Million | €-4.71 Million | €26.61 Million | ▼ -580.8% |
| 2016 | -0.03x | €-686.39K | €-5.01 Million | €27.02 Million | ▼ -154.7% |
| 2015 | 0.05x | €610.79K | €523.14K | €13.14 Million | ▼ -95.4% |
| 2014 | 1.00x | €12.17 Million | €12.13 Million | €12.16 Million | ▲ +15.4% |
| 2013 | 0.87x | €12.17 Million | €12.13 Million | €14.04 Million | — |